L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells
Titel:
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells
Auteur:
Jung, Soo-A. Lee, Dae-Hee Moon, Jai-Hee Hong, Seung-Woo Shin, Jae-Sik Hwang, Ih Yeon Shin, Yu Jin Kim, Jeong Hee Gong, Eun-Yeung Kim, Seung-Mi Lee, Eun Young Lee, Seul Kim, Jeong Eun Kim, Kyu-pyo Hong, Yong Sang Lee, Jung Shin Jin, Dong-Hoon Kim, TaeWon Lee, Wang Jae